Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Psychological Bulletin|February 27, 2008
Hot flashes and panic attacks: a comparison of symptomatology, neurobiology, treatment, and a role for cognitionLaura J Hanisch, Liisa Hantsoo, Ellen W Freeman, et al.
The International Journal of Neuropsychopharmacology|December 25, 2014
Cerebrospinal fluid neuropeptide Y levels in major depression and reported childhood traumaLaili Soleimani, Maria A Oquendo, Gregory M Sullivan, et al.
Pain Medicine (Malden, Mass.)|July 8, 2025
Pain Relief by Targeting Nonrestorative Sleep in Fibromyalgia: A Phase 3 Randomized Trial of Bedtime Sublingual CyclobenzaprineSeth Lederman, Lesley M Arnold, Ben Vaughn, et al.
Biological Psychiatry|June 9, 2004
The selective serotonin reuptake inhibitor citalopram increases fear after acute treatment but reduces fear with chronic treatment: a comparison with tianeptineNesha S Burghardt, Gregory M Sullivan, Bruce S McEwen, et al.
Psychiatry Research|February 18, 2004
Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatmentGregory M Sullivan, Justine M Kent, Marc Kleber, et al.
Biological Psychiatry|February 21, 2006
Low cerebrospinal fluid transthyretin levels in depression: correlations with suicidal ideation and low serotonin functionGregory M Sullivan, J John Mann, Maria A Oquendo, et al.
Psychiatry Research|February 13, 2024
A phase 3, randomized, placebo-controlled, trial to evaluate the efficacy and safety of bedtime sublingual cyclobenzaprine (TNX-102 SL) in military-related posttraumatic stress disorderMegan E Parmenter, Seth Lederman, Frank W Weathers, et al.
Biological Psychiatry|July 26, 2005
Brain serotonin1A receptor binding in major depression is related to psychic and somatic anxietyGregory M Sullivan, Maria A Oquendo, Norman Simpson, et al.
Depression and Anxiety|February 15, 2013
Higher in vivo serotonin-1a binding in posttraumatic stress disorder: a PET study with [11C]WAY-100635Gregory M Sullivan, R Todd Ogden, Yung-Yu Huang, et al.
Synapse (New York, N.Y.)|May 31, 2013
Higher pretreatment 5-HT1A receptor binding potential in bipolar disorder depression is associated with treatment remission: a naturalistic treatment pilot PET studyMartin J Lan, Natalie Hesselgrave, Adam Ciarleglio, et al.
Pageof 5